RedChip Companies
|
Weekly Newsletter
|
|
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
|
Immunome (Nasdaq: IMNM), a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop antibody therapeutics to improve patient care, today announced the publication of data highlighting efficacy of its preclinical IL-38 blocking antibody, titled “IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activation,” in the peer-reviewed journal mAbs. The data in the article demonstrates that antibody-based targeting of IL-38 reactivates the immunostimulatory anti-tumor mechanisms within the tumor microenvironment in preclinical testing.
For more information, visit www.immunome.com
|
Reviva Pharmaceuticals Announced Preclinical Efficacy Data on Brilaroxazine in IPF at the 2023 American Thoracic Society International Conference and Publication in Medical Research Archives
Reviva Pharmaceuticals (Nasdaq: RVPH), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), respiratory and metabolic diseases, has presented preclinical data on the novel serotonin-dopamine modulator brilaroxazine in idiopathic pulmonary fibrosis (IPF) at the 2023 American Thoracic Society (ATS) International Conference which took place in Washington, DC, USA, May 19-24, 2023. The Company also announced acceptance of this data for publication in Medical Research Archives.
|
SPI Energy Signs Agreement to Sell an 18.25MW Community Solar Portfolio in Oregon to Luminace
SPI Energy (Nasdaq: SPI), a global renewable energy company and provider of solar, storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers, announced that the company signed an agreement to sell an 18.25MW community solar portfolio in Oregon (the "Oregon Portfolio") to Luminace. Luminace is the North American decarbonization-as-a-service platform of Brookfield Renewable and has an operational and development portfolio of more than 4,000 megawatts of distributed energy resources.
|
|
|
SPI Energy Reports Revenue Up 24.4% to $47.9 Million in Q1 2023
SPI Energy (Nasdaq: SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers, announced its financial results for the first quarter ended March 31, 2023 and reaffirmed its 2023 guidance of $250 million to $300 million revenues and $29 million to $36 million net profit.
|
GeneType featured on U.S. National TV to raise Breast Cancer Awareness
Genetic Technologies (Nasdaq: GENE), a global leader in genomics-based tests in health, wellness and serious disease is pleased to announce that the Company’s geneType Breast Cancer Risk Assessment Test featured on “The Balancing Act” program, which is broadcast on national television in the US.
|
|
|
Upcoming Events |
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
11:00am Eastern |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NYSE American: GNS - Genius Group |
11:00am Eastern |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
11:00am Eastern |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. With the Company’s unique cognitive sensor fusion technology, based on advanced electrooptic sensors, artificial intelligence and deep learning. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
4:15pm Eastern |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
OTCQB: QYOUF - QYOU Media |
4:15pm Eastern |
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
4:15pm Eastern |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Archive Events |
|
|
|
NASDAQ: SNGX - Soligenix |
Meeting Duration 48 minutes |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
NASDAQ: SPI - SPI Energy |
Meeting Duration 145 minutes |
We are delighted to invite you to SPI Energy's Investor Day 2023, where you will have the chance to learn more about our strategic vision and growth plans and hear from key members of our leadership team. |
|
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 43 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
Meeting Duration 35 minutes |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
NASDAQ: UNCY - Unicycive Therapeutics |
Meeting Duration 28 minutes |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 32 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 30 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 38 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
Meeting Duration 37 minutes |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
Meeting Duration 44 minutes |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
Lesson of the Week
Small-cap stocks often have high betas. Learn what that means in this week's lesson.
|
|
|
MidSouth Week in Review
The Dollar hit a two-month high at 104 after nearly dropping below 100 in April. Stocks fell as the debt ceiling negotiations continue.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|